Latest Thalidomide Stories
NEW YORK, Aug. 3 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) announced today that it has reached agreement with the U.S.
Treating patients with thalidomide in combination with chemotherapy for small cell lung cancer (SCLC) did not improve their survival but did increase their risk of blood clots, according to a new study published online July 16 in the Journal of the National Cancer Institute.
Researchers in Israel have shown that the anti-nausea drug metoclopramide does no obvious harm to the fetus in pregnant women.
Carfilzomib Achieves 26 Percent Clinical Benefit Response Rate in Phase 2 Trial of Relapsed and Refractory Multiple Myeloma Patients - Proteolix Expands Trial ORLANDO, Fla. and SOUTH SAN FRANCISCO, Calif., June 1 /PRNewswire/ -- Proteolix, Inc.
Results from Phase 2 Clinical Trials of Carfilzomib in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Featured in Oral Presentations SOUTH SAN FRANCISCO, May 15 /PRNewswire/ -- Proteolix, Inc.
Scientists studying how marine bacteria move have discovered that a sharp variation in water current segregates right-handed bacteria from their left-handed brethren, impelling the microbes in opposite directions.
Thalidomide victims once snubbed by the German government are being offered compensation for birth defects caused by the drug, officials say. The German family ministry has announced it will temporarily waive a 26-year-old ban on considering thalidomide relief claims from foreign countries until the end of 2010, thus enabling victims from around the world to collect damages on the drug formerly made by the German company Grunenthal, The Sunday Times of London reported. Germany since 1983 has...
New subset analysis of bortezomib-relapsed patient population demonstrates 55% overall response rate and extended time to progression NEW YORK, Feb. 26 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc.
Thalidomide victims in Britain say the government is denying them financial aid as they age and their health worsens. It's estimated more than 450 people whose mothers took thalidomide during pregnancy are nearing 50 and suffering physical breakdowns, The Sunday Times of London reported. Thousands of British mothers were prescribed thalidomide as a cure for morning sickness, and gave birth to babies who then died or grew up with drastically stunted arms and fingers and no shoulder joints....
SOUTH SAN FRANCISCO, Calif., Dec. 9 /PRNewswire/ -- Proteolix, Inc. today announced positive clinical data demonstrating that the company's lead product, carfilzomib, has single-agent activity and promotes durable responses in patients with relapsed and refractory multiple myeloma.
- A trick or prank.